|
XPNPEP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.48780004877369E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.433040E-01 |
| Stage1-vs-Stage3 |
1.159980E-01 |
| Stage1-vs-Stage4 |
1.244020E-02 |
| Stage2-vs-Stage3 |
2.482300E-02 |
| Stage2-vs-Stage4 |
2.682900E-03 |
| Stage3-vs-Stage4 |
1.984590E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.09299999956947E-07 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
9.071900E-02 |
| Caucasian-vs-Asian |
7.188000E-04 |
| AfricanAmerican-vs-Asian |
3.019500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
1.850020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
2.90711898998097E-12 |
| Normal-vs-Age(81-100Yrs) |
9.28860000026788E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.058800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.943980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.428200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.191990E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.941200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.423580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.627400E-04 |
| Classical-VS-Follicular |
4.222900E-03 |
| Classical-VS-Other |
7.382600E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.58790000004405E-06 |
| Tall-VS-Other |
2.128000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.543400E-01 |
| Follicular-VS-Normal |
3.61050078723224E-11 |
| Other-VS-Normal |
4.25400000003684E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.618650E-04 |
|
|
